相关实验视频
Updated: Jun 28, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.1K
探戈需要两个人. 确定基于绩效的风险共享安排对双方有效的条件
Adrian Towse1, Elisabeth Fenwick2
1Senior Visiting Fellow, Office of Health Economics, London, UK.
概括
基于绩效的风险分担安排可以通过解决支付人对产品价值的不确定性来改善患者获得创新治疗的机会. 这种方法解决了创新者和付款者之间的分歧,使双方都受益.
科学领域:
- 卫生经济学 卫生经济学
- 卫生技术评估 卫生技术评估
- 制药政策 制药政策
背景情况:
- 加快审批途径旨在加快患者获取,但往往面临付款人的成本效益和价值的不确定性.
- 基于绩效的风险分担安排 (RSRA) 提供了一种机制,以管理创新者和付款人之间的不确定性.
- 现有的文献缺乏一个正式的框架来应用RSRA来解决对产品价值的不同期望.
研究的目的:
- 探索RSRA在产品价值和成本效益方面弥合创新者和付款人的观点之间的差距的潜力.
- 制定一个框架,以确定RSRA可以加强通过加速途径批准的产品的报销计划的情况.
- 分析RSRA为制药创新者和医疗保健支付人创造价值的条件.
主要方法:
- 利用信息框架的价值来模拟付款人和创新者的成本效益和研究价值的观点.
- 开发了5个分析规则来评估16个不同的付款人和创新者的期望情景.
- 评估了诸如研究资金和管理成本等因素对RSRAs可行性的影响.
主要成果:
- 风险分担安排在16个分析的场景中,在9个场景中提供了更好的解决方案.
- 该研究确定了付款人和创新者期望的特定组合,其中RSRA是最有益的.
- 研究和管理成本的分配对风险分担协议的有效性产生重大影响.
结论:
- RSRAs可以有效地解决付款人的不确定性,并促进患者更早地获得创新的治疗方法.
- 实施需要采取实际措施,确保付款人采用,可能涉及与全球市场激励措施一致的创新者承担的成本.
- 成功的RSRA提供了诸如提高卫生系统效率,充满信心的付款人支出和提高创新者回报等好处.
更多相关视频
13:04Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
12.1K
06:18The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm
Published on: October 20, 2022
2.1K
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:20Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
01:22Design Consideration
186
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
The factor of safety is another key...
186
01:04Social Facilitation
32.0K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
32.0K
01:11Hazard Rate
104
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
104
01:12Hazard Ratio
116
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
116